Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Other Non-Current Assets (2020 - 2025)

HCW Biologics (HCWB) has disclosed Other Non-Current Assets for 6 consecutive years, with $28476.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Assets changed 0.0% year-over-year to $28476.0, compared with a TTM value of $28476.0 through Sep 2025, changed 0.0%, and an annual FY2024 reading of $28476.0, down 49.63% over the prior year.
  • Other Non-Current Assets was $28476.0 for Q3 2025 at HCW Biologics, roughly flat from $28477.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $686414.0 in Q1 2022 and bottomed at $28476.0 in Q1 2024.
  • Average Other Non-Current Assets over 5 years is $203362.9, with a median of $97082.0 recorded in 2023.
  • The sharpest move saw Other Non-Current Assets soared 1048.64% in 2021, then crashed 88.75% in 2024.
  • Year by year, Other Non-Current Assets stood at $393318.0 in 2021, then fell by 15.11% to $333875.0 in 2022, then plummeted by 83.07% to $56538.0 in 2023, then tumbled by 49.63% to $28476.0 in 2024, then changed by 0.0% to $28476.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for HCWB at $28476.0 in Q3 2025, $28477.0 in Q2 2025, and $28476.0 in Q1 2025.